Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience

  • Michael G. Fradley | mfradley@health.usf.edu Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States.
  • Allen C. Brown Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States.
  • Bernadette Shields Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
  • Federico Viganego Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States.
  • Rongras Damrongwatanasuk Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States.
  • Aarti A. Patel Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States.
  • Gregory Hartlage Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States.
  • Natalee Roper Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
  • Julie Jaunese Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
  • Larry Roy Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
  • Roohi Ismail-Khan Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Women’s Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.

Abstract

Cardio-oncology is a multidisciplinary field focusing on the management and prevention of cardiovascular complications in cancer patients and survivors. While the initial focus of this specialty was on heart failure associated with anthracycline use, novel anticancer agents are increasingly utilized and are associated with many other cardiotoxicities including hypertension, arrhythmias and vascular disease. Since its inception, the field has developed at a rapid pace with the establishment of programs at many major academic institutions and community practices. Given the complexities of this patient population, it is important for providers to possess knowledge of not only cardiovascular disease but also cancer subtypes and their specific therapeutics. Developing a cardio- oncology program at a stand-alone cancer center can present unique opportunities and challenges when compared to those affiliated with other institutions including resource allocation, cardiovascular testing availability and provider education. In this review, we present our experiences establishing the cardio-oncology program at Moffitt Cancer Center and provide guidance to those individuals interested in developing a program at a similar independent cancer institution.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2017-07-18
Info
Issue
Section
Reviews
Keywords:
Cardio-Oncology, cardiotoxicity, chemotherapy.
Statistics
  • Abstract views: 1788

  • PDF: 882
  • HTML: 302
How to Cite
Fradley, M. G., Brown, A. C., Shields, B., Viganego, F., Damrongwatanasuk, R., Patel, A. A., Hartlage, G., Roper, N., Jaunese, J., Roy, L., & Ismail-Khan, R. (2017). Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience. Oncology Reviews, 11(2). https://doi.org/10.4081/oncol.2017.340